We first examined saccade amplitude with a one-way analysis of variance including stage (baseline versus posttest) as a factor. We then determined the period at the beginning of the adaptation stage when amplitude was different from baseline but had not yet reached the stable level at the end of the adaptation stage. This time period was singled out for every subject and every session and was called “during adaptation.” We compared the dynamics of this stage to those observed before adaptation (baseline) and after adaptation (posttest). The during-adaptation stage was identified by the following linear interpolation procedure. For each data point, the slope of the linear relationship between saccade amplitude and trial number was calculated taking successively more and more data points into account. The minimal trial number (
T min) was fixed at trial 1, and the slope calculated for trials 1 to 6. The slope was then calculated for trials 1 to 7, then 1 to 8, and so forth, each time adding one more trial. No systematic amplitude changes were expected during baseline; therefore, we expected the slope to oscillate around 0. We expected the slope to depart from 0 at some point early in the adaptation stage when a systematic amplitude change occurred. Thus, the first data point where the slope differed from 0 was marked as the onset of the during-adaptation stage. The offset of the adaptation stage was calculated in a similar manner. The last trial of the adaptation condition was fixed (
T max, trial 160), and the slope calculated for the six preceding trials (trials 154–160), then for trials 153 to 160, and so forth. Again, no systematic amplitude changes were expected at the end of the adaptation stage, and we expected the slope to oscillate around 0. The first data point where the slope differed from 0 was marked as the offset of the during-adaptation stage
(Fig. 1) .
The average during-adaptation stage spanned trials 73 ± 7 to 114 ± 8. However, because adaptation was variable between and within subjects on different sessions,
3 each individual session was treated separately. Therefore, the exact number of trials included in the during-adaptation stage varied from individual to individual and from session to session.
We grouped the data into three amplitude classes where we obtained data in all baseline, during-adaptation and posttest stages: 8° to 8.9° (average number of observations per subject: 110 ± 28 baseline, 161 ± 44, during-adaptation, 69 ± 23 posttest), 9° to 9.9° (average number of observations per subject: 93 ± 31, 59 ± 25, and 73 ± 14 for the three stages, respectively), and 10° to 10.9° (average number of observations per subject: 35 ± 20, 7 ± 5, and 65 ± 18). We examined duration, peak velocity, acceleration, deceleration, and skewness ratio (time between saccade onset and peak velocity/time from peak velocity to saccade offset). Analyses of variance were performed with amplitude (8°, 9°, and 10°) and stage (baseline, during-adaptation, and posttest) as factors. Probabilities are given in parentheses.